DeepMed Research

Peking University Peoples Hospital

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

The Effectiveness and Safety of the Prolonged Down-regulation Protocol for Controlled Ovarian Hyperstimulation

Phase 4

Conditions: Infertility, Female

Interventions: Drug: Triptorelin acetate

First Posted Date: 2019-01-18

Last Posted Date: 2019-01-18

Lead Sponsor: Peking University People's Hospital

Target Recruit Count: 1892

Registration Number: NCT03809221

Efficacy Management and Adherence Evaluation of Diclofenac in the Treatment of Knee Osteoarthritis Pain

Not Applicable

Conditions: To Investigate the Effect of Diclofenac on Pain Control of Knee Osteoarthritis and the Relationship Between Pain Relief and Medicine Adherence

First Posted Date: 2019-01-16

Last Posted Date: 2019-01-16

Lead Sponsor: Peking University People's Hospital

Target Recruit Count: 120

Registration Number: NCT03806205

Locations: 🇨🇳
Peking University People's Hospital, Beijing, Xicheng District, China

Decitabine Plus mBU/CY Preconditioning for Relapse/Refractory Acute Leukemia

Phase 2

Conditions: Stem Cell Transplant Complications
Relapse Leukemia
Refractory Leukemia

Interventions: Drug: Decitabine
Drug: mBU/CY and ATG
Drug: mBU/CY

First Posted Date: 2019-01-10

Last Posted Date: 2019-05-29

Lead Sponsor: Peking University People's Hospital

Target Recruit Count: 55

Registration Number: NCT03799224

Locations: 🇨🇳
Peking University Institute of Hematology,Beijing, Beijing, Beijing, China

Prediction Model for Multiple Pulmonary Nodules

Completed

Conditions: Multiple Pulmonary Nodules

First Posted Date: 2019-01-07

Last Posted Date: 2019-08-28

Lead Sponsor: Peking University People's Hospital

Target Recruit Count: 59

Registration Number: NCT03795181

Locations: 🇨🇳
Peking University People's Hospital, Beijing, China

Decitabine Plus mBU/CY for High Risk Acute Leukemia With MRD Pre-HSCT

Phase 2

Recruiting

Conditions: Leukemia Relapse
Stem Cell Transplant Complications
Leukemia, Myeloid, Acute

Interventions: Drug: Decitabine
Drug: mBU/CY
Drug: mBU/CY and ATG

First Posted Date: 2019-01-04

Last Posted Date: 2020-03-10

Lead Sponsor: Peking University People's Hospital

Target Recruit Count: 55

Registration Number: NCT03793517

Locations: 🇨🇳
Peking University Institute of Hematology,Beijing, Beijing, Beijing, China

The Value of High-resolution Ultrasound in the Detection of Lymph Node Metastasis: a Proposal of NI-RADS

Completed

Conditions: Breast Neoplasms

Interventions: Diagnostic Test: Ultrasound evaluation

First Posted Date: 2019-01-03

Last Posted Date: 2022-10-18

Lead Sponsor: Peking University People's Hospital

Target Recruit Count: 135

Registration Number: NCT03791840

Locations: 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China

Light-CT in the Diagnosis of Breast Tumor and Lymph Node

Conditions: Breast Neoplasms

Interventions: Diagnostic Test: Light-CT

First Posted Date: 2019-01-03

Last Posted Date: 2021-12-21

Lead Sponsor: Peking University People's Hospital

Target Recruit Count: 150

Registration Number: NCT03791853

Locations: 🇨🇳
Beijing Chaoyang Hospital, Beijing, China
🇨🇳
Breast Center, Peking University People's Hospital, Beijing, Beijing, China
🇨🇳
Xuanwu Hospital of Capital Medical University, Beijing, China

A Multi-center Clinical Study on the Status of Trauma Evaluating Ability in Patients With Multiple Trauma

Conditions: Multiple Trauma/Injuries

Interventions: Other: injury severity score

First Posted Date: 2019-01-02

Last Posted Date: 2019-01-02

Lead Sponsor: Peking University People's Hospital

Target Recruit Count: 3600

Registration Number: NCT03791333

Sentinel Lymph Node Mapping In Cervical Cancer

Not Applicable

Conditions: Uterine Cervical Neoplasms

Interventions: Procedure: sentinel lymph node biopsy

First Posted Date: 2018-12-19

Last Posted Date: 2018-12-19

Lead Sponsor: Peking University People's Hospital

Target Recruit Count: 1143

Registration Number: NCT03778268

Locations: 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China

Sentinel Lymph Node Mapping In Endometrial Cancer

Not Applicable

Conditions: Endometrial Neoplasms

Interventions: Procedure: Sentinel Lymph Node Biopsy

First Posted Date: 2018-12-19

Last Posted Date: 2018-12-19

Lead Sponsor: Peking University People's Hospital

Target Recruit Count: 635

Registration Number: NCT03778255

Locations: 🇨🇳
Peking University People's Hosoital, Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy